Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 18 Feb 2025 – 20 Aug 2026, limited by UTI Nifty India Manufacturing Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | UTI Nifty India Manufacturing Index Fund | Nifty 500 |
|---|---|---|
| 18 Feb 2025 | ₹100.00 | ₹100.00 |
| 05 Apr 2025 | ₹99.64 | ₹100.94 |
| 20 May 2025 | ₹111.13 | ₹109.58 |
| 05 Jul 2025 | ₹115.88 | ₹114.32 |
| 20 Aug 2025 | ₹115.23 | ₹112.28 |
| 04 Oct 2025 | ₹118.53 | ₹111.72 |
| 19 Nov 2025 | ₹121.22 | ₹115.99 |
| 04 Jan 2026 | ₹123.47 | ₹116.92 |
| 18 Feb 2026 | ₹124.46 | ₹114.72 |
| 05 Apr 2026 | ₹112.02 | ₹101.59 |
| 21 May 2026 | ₹124.46 | ₹109.66 |
| 05 Jul 2026 | ₹126.19 | ₹113.05 |
| 20 Aug 2026 | ₹130.66 | ₹114.08 |
| Metric | UTI · Regular NAV ₹12.77 Very High risk ★★★★★ 1Y | Category median Index Funds · 366 funds |
|---|---|---|
| +13.40% | +5.43% | |
| — | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| +19.51% | +7.40% | |
| +15.66% | — | |
| — | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 15.78% | 13.88% | |
| 0.44 | 0.25 | |
| 0.62 | 0.35 | |
| -12.18% | -16.66% | |
| Nifty 500 | — | |
| — | +0.30% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 98.8% | |
| 1.13% | 0.96% | |
| ₹28.58Cr | ₹182.17Cr | |
| None | — | |
| None | — | |
| ₹2.02K | — | |
| ₹1.00K | — | |
| 37% | 35% | |
| Sharwan Kumar Goyal | — | |
| 18 Feb 2025 | — | |
| 76 | — | |
| 38.1% | — | |
| 0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.